Results 151 to 160 of about 11,486,847 (294)

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Caring Behaviours in Nursing: A Bibliometric Analysis of Global Research Trends and Knowledge Structure. [PDF]

Scand J Caring Sci
Özkan İ, Taylan S.
europepmc   +1 more source

Africa’s Regulatory Revolution: How Harmonized Regulation Can Transform Global Clinical Trials

Open Access Journal of Clinical Trials
Henriette U Balinda, Alima Tchafa, Franck Tchafa Publication Department, Feat Healthcare, Dallas, TX, USACorrespondence: Henriette U Balinda, Publication Department, Feat Healthcare, 539 W. Commerce St.
Balinda HU, Tchafa A, Tchafa F
doaj  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

International Research Collaboration Supported by the U.S. National Institutes of Health: An Analysis of Coauthor Country Affiliations - 2014-23. [PDF]

Ann Glob Health
Kilmarx PH, Kyere S.
europepmc   +1 more source

Publications of the Bureau of Plant Industry.

"Division of Publications, Circular no.12."Mode of access: Internet.Latest issue consulted: Feb. 16, 1912.Description based on: Issued Feb.
United States. Dept. of Agriculture. Division of Publications.
core  

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Bibliometric analysis of slope-correcting osteotomy in the context of anterior cruciate ligament reconstruction: key trends, contributors and themes. [PDF]

Eur J Orthop Surg Traumatol
Loharuka A, Zilani N, Raj S, Babbar D, Mohammad HR, Razak H, Ollivier M.   +6 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Publicity for Public Health

American Journal of Public Health and the Nations Health, 1929
openaire   +3 more sources